209 related articles for article (PubMed ID: 15610731)
1. The SRF target gene Fhl2 antagonizes RhoA/MAL-dependent activation of SRF.
Philippar U; Schratt G; Dieterich C; Müller JM; Galgóczy P; Engel FB; Keating MT; Gertler F; Schüle R; Vingron M; Nordheim A
Mol Cell; 2004 Dec; 16(6):867-80. PubMed ID: 15610731
[TBL] [Abstract][Full Text] [Related]
2. Regulation of myocardin factor protein stability by the LIM-only protein FHL2.
Hinson JS; Medlin MD; Taylor JM; Mack CP
Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1067-H1075. PubMed ID: 18586895
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.
Lockman K; Hinson JS; Medlin MD; Morris D; Taylor JM; Mack CP
J Biol Chem; 2004 Oct; 279(41):42422-30. PubMed ID: 15292266
[TBL] [Abstract][Full Text] [Related]
4. RhoA as a mediator of clinically relevant androgen action in prostate cancer cells.
Schmidt LJ; Duncan K; Yadav N; Regan KM; Verone AR; Lohse CM; Pop EA; Attwood K; Wilding G; Mohler JL; Sebo TJ; Tindall DJ; Heemers HV
Mol Endocrinol; 2012 May; 26(5):716-35. PubMed ID: 22456196
[TBL] [Abstract][Full Text] [Related]
5. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.
Liu HW; Halayko AJ; Fernandes DJ; Harmon GS; McCauley JA; Kocieniewski P; McConville J; Fu Y; Forsythe SM; Kogut P; Bellam S; Dowell M; Churchill J; Lesso H; Kassiri K; Mitchell RW; Hershenson MB; Camoretti-Mercado B; Solway J
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):39-47. PubMed ID: 12600823
[TBL] [Abstract][Full Text] [Related]
6. Interaction of serum response factor (SRF) with the Elk-1 B box inhibits RhoA-actin signaling to SRF and potentiates transcriptional activation by Elk-1.
Murai K; Treisman R
Mol Cell Biol; 2002 Oct; 22(20):7083-92. PubMed ID: 12242287
[TBL] [Abstract][Full Text] [Related]
7. Identification of a RhoA- and SRF-dependent mechanism of androgen action that is associated with prostate cancer progression.
Heemers HV
Curr Drug Targets; 2013 Apr; 14(4):481-9. PubMed ID: 23469924
[TBL] [Abstract][Full Text] [Related]
8. The four-and-a-half LIM domain protein 2 regulates vascular smooth muscle phenotype and vascular tone.
Neuman NA; Ma S; Schnitzler GR; Zhu Y; Lagna G; Hata A
J Biol Chem; 2009 May; 284(19):13202-12. PubMed ID: 19265191
[TBL] [Abstract][Full Text] [Related]
9. Megakaryoblastic leukemia 1, a potent transcriptional coactivator for serum response factor (SRF), is required for serum induction of SRF target genes.
Cen B; Selvaraj A; Burgess RC; Hitzler JK; Ma Z; Morris SW; Prywes R
Mol Cell Biol; 2003 Sep; 23(18):6597-608. PubMed ID: 12944485
[TBL] [Abstract][Full Text] [Related]
10. Serum response factor is crucial for actin cytoskeletal organization and focal adhesion assembly in embryonic stem cells.
Schratt G; Philippar U; Berger J; Schwarz H; Heidenreich O; Nordheim A
J Cell Biol; 2002 Feb; 156(4):737-50. PubMed ID: 11839767
[TBL] [Abstract][Full Text] [Related]
11. RPEL motifs link the serum response factor cofactor MAL but not myocardin to Rho signaling via actin binding.
Guettler S; Vartiainen MK; Miralles F; Larijani B; Treisman R
Mol Cell Biol; 2008 Jan; 28(2):732-42. PubMed ID: 18025109
[TBL] [Abstract][Full Text] [Related]
12. Androgen induction of the androgen receptor coactivator four and a half LIM domain protein-2: evidence for a role for serum response factor in prostate cancer.
Heemers HV; Regan KM; Dehm SM; Tindall DJ
Cancer Res; 2007 Nov; 67(21):10592-9. PubMed ID: 17975004
[TBL] [Abstract][Full Text] [Related]
13. Diaphanous 1 and 2 regulate smooth muscle cell differentiation by activating the myocardin-related transcription factors.
Staus DP; Blaker AL; Taylor JM; Mack CP
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):478-86. PubMed ID: 17170370
[TBL] [Abstract][Full Text] [Related]
14. Nuclear translocation of the SRF co-activator MAL in cortical neurons: role of RhoA signalling.
Tabuchi A; Estevez M; Henderson JA; Marx R; Shiota J; Nakano H; Baraban JM
J Neurochem; 2005 Jul; 94(1):169-80. PubMed ID: 15953360
[TBL] [Abstract][Full Text] [Related]
15. The FHL2 regulation in the transcriptional circuitry of human cancers.
Cao CY; Mok SW; Cheng VW; Tsui SK
Gene; 2015 Nov; 572(1):1-7. PubMed ID: 26211626
[TBL] [Abstract][Full Text] [Related]
16. PIAS1 activates the expression of smooth muscle cell differentiation marker genes by interacting with serum response factor and class I basic helix-loop-helix proteins.
Kawai-Kowase K; Kumar MS; Hoofnagle MH; Yoshida T; Owens GK
Mol Cell Biol; 2005 Sep; 25(18):8009-23. PubMed ID: 16135793
[TBL] [Abstract][Full Text] [Related]
17. Reorganization of the actin cytoskeleton via transcriptional regulation of cytoskeletal/focal adhesion genes by myocardin-related transcription factors (MRTFs/MAL/MKLs).
Morita T; Mayanagi T; Sobue K
Exp Cell Res; 2007 Oct; 313(16):3432-45. PubMed ID: 17714703
[TBL] [Abstract][Full Text] [Related]
18. Smooth muscle gamma-actin promoter regulation by RhoA and serum response factor signaling.
Carson JA; Culberson DE; Thompson RW; Fillmore RA; Zimmer W
Biochim Biophys Acta; 2003 Jul; 1628(2):133-9. PubMed ID: 12890560
[TBL] [Abstract][Full Text] [Related]
19. Differential regulation of Hand1 homodimer and Hand1-E12 heterodimer activity by the cofactor FHL2.
Hill AA; Riley PR
Mol Cell Biol; 2004 Nov; 24(22):9835-47. PubMed ID: 15509787
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell-cell contacts regulate SRF-mediated transcription via Rac-actin-MAL signalling.
Busche S; Descot A; Julien S; Genth H; Posern G
J Cell Sci; 2008 Apr; 121(Pt 7):1025-35. PubMed ID: 18334560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
